{"id":23366,"date":"2020-09-09T00:00:00","date_gmt":"2020-09-09T05:00:00","guid":{"rendered":"https:\/\/myeloma.ca\/2020\/09\/09\/loms-ajoute-a-ses-orientations-cliniques-des-recommandations-sur-lutilisation-des-corticosteroides\/"},"modified":"2020-09-09T00:00:00","modified_gmt":"2020-09-09T05:00:00","slug":"loms-ajoute-a-ses-orientations-cliniques-des-recommandations-sur-lutilisation-des-corticosteroides","status":"publish","type":"post","link":"https:\/\/myeloma.ca\/fr\/2020\/09\/09\/loms-ajoute-a-ses-orientations-cliniques-des-recommandations-sur-lutilisation-des-corticosteroides\/","title":{"rendered":"L\u2019OMS ajoute \u00e0 ses orientations cliniques des recommandations sur l\u2019utilisation des corticost\u00e9ro\u00efdes"},"content":{"rendered":"<p>Nous recommandons l&rsquo;utilisation de corticost&eacute;ro&iuml;des syst&eacute;miques pour le traitement des patients atteints d&rsquo;une forme grave ou critique de COVID-19. Nous sugg&eacute;rons de ne pas utiliser de corticost&eacute;ro&iuml;des pour traiter les patients atteints d&rsquo;une forme b&eacute;nigne de la maladie car, dans cette situation, le traitement ne pr&eacute;sente &nbsp;aucun avantage et pourrait m&ecirc;me s&rsquo;av&eacute;rer nocif. Le traitement doit &ecirc;tre pris sous surveillance m&eacute;dicale. Cliquez <strong><a href=\"https:\/\/www.who.int\/fr\/news-room\/feature-stories\/detail\/who-updates-clinical-care-guidance-with-corticosteroid-recommendations\" target=\"_blank\" rel=\"noopener\">ici<\/a>&nbsp;<\/strong>pour lire la suite.&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nous recommandons l&rsquo;utilisation de corticost&eacute;ro&iuml;des syst&eacute;miques pour le traitement des patients atteints d&rsquo;une forme grave ou critique de COVID-19. Nous sugg&eacute;rons de ne pas utiliser de corticost&eacute;ro&iuml;des pour traiter les patients atteints d&rsquo;une forme b&eacute;nigne de la maladie car, dans cette situation, le traitement ne pr&eacute;sente &nbsp;aucun avantage et pourrait m&ecirc;me s&rsquo;av&eacute;rer nocif. Le traitement [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[72],"tags":[],"class_list":["post-23366","post","type-post","status-publish","format-standard","hentry","category-actualites-et-nouvelles-au-sujet-de-la-covid-19"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/23366","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=23366"}],"version-history":[{"count":0,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/23366\/revisions"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=23366"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/categories?post=23366"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=23366"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}